Drug delivery systems provider Aptar Pharma, has announced that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. Read more

North America

Women who have had complications following pelvic mesh implants and have had to have corrective surgery are increasingly likely to suffer from depression and possibly self-harm, according to a study by researchers at ICES. Read more

North America

At Medica 2016, Axilum Robotics, a spin-off company of medical robotics research group ICube, has announced its latest product to help patients living with chronic pain and other conditions. Read more